ArticleScientific reports2018

Effectiveness and Safety of Different Rivaroxaban Dosage Regimens in Patients with Non-Valvular Atrial Fibrillation: A Nationwide, Population-Based Cohort Study.

Hsin-Yi Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.